We are live on ! Find out more
ACH

ArrowMark Colorado Holdings Portfolio holdings

AUM $3.76B
1-Year Est. Return 21.77%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+21.77%
3 Year Est. Return
+58.74%
5 Year Est. Return
+55.15%
10 Year Est. Return
+474.07%
AUM
$7.33B
AUM Growth
+$1B
Cap. Flow
+$568M
Cap. Flow %
7.75%
Top 10 Hldgs %
19.96%
Holding
320
New
26
Increased
127
Reduced
80
Closed
21

Sector Composition

Rank Sector Weight
1 Industrials 27.64%
2 Technology 20.82%
3 Healthcare 17.21%
4 Consumer Discretionary 12.24%
5 Financials 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPR icon
51
Cimpress
CMPR
$2.46B
$53.3M 0.73%
618,186
+121,873
+25% +$10.5M
PDCO
52
DELISTED
Patterson Companies, Inc.
PDCO
$52.8M 0.72%
1,166,791
+101,794
+10% +$4.42M
MD icon
53
Pediatrix Medical
MD
$2.06B
$52.6M 0.72%
758,188
-7,653
-1% -$532K
ELGX
54
DELISTED
Endologix Inc
ELGX
$51.5M 0.7%
711,967
+62,802
+10% +$4.15M
RBA icon
55
RB Global
RBA
$20.7B
$49.7M 0.68%
1,509,673
+770,608
+104% +$25M
CASY icon
56
Casey's General Stores
CASY
$31.8B
$47.2M 0.64%
+420,082
New +$48.2M
ECOM
57
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$45.3M 0.62%
4,063,437
-33,445
-0.8% -$413K
CBOE icon
58
Cboe Global Markets
CBOE
$30.3B
$45.1M 0.62%
+556,699
New +$43.5M
DXCM icon
59
DexCom
DXCM
$32.9B
$44.2M 0.6%
2,088,032
-71,524
-3% -$1.4M
NBIX icon
60
Neurocrine Biosciences
NBIX
$17.1B
$43.6M 0.59%
1,006,998
+115,471
+13% +$4.95M
HIBB
61
DELISTED
Hibbett, Inc. Common Stock
HIBB
$42M 0.57%
1,423,238
-1,110,172
-44% -$34.8M
CSGP icon
62
CoStar Group
CSGP
$12B
$41.8M 0.57%
2,017,920
+177,050
+10% +$3.6M
RVNC
63
DELISTED
Revance Therapeutics, Inc.
RVNC
$40.1M 0.55%
1,926,862
-91,867
-5% -$1.89M
OZK icon
64
Bank OZK
OZK
$5.71B
$39.9M 0.54%
767,051
+62,916
+9% +$3.38M
ATRA icon
65
Atara Biotherapeutics
ATRA
$80.4M
$39.7M 0.54%
77,261
+14,837
+24% +$6.14M
ABMD
66
DELISTED
Abiomed Inc
ABMD
$39.1M 0.53%
312,155
+79,613
+34% +$9.23M
DDD icon
67
3D Systems Corp
DDD
$568M
$38.6M 0.53%
+2,577,469
New +$40.4M
EEFT icon
68
Euronet Worldwide
EEFT
$2.87B
$37.5M 0.51%
437,933
+40,547
+10% +$3.19M
BLUE
69
DELISTED
bluebird bio
BLUE
$37.2M 0.51%
31,598
-3,401
-10% -$3.47M
SPSC icon
70
SPS Commerce
SPSC
$2.67B
$35.3M 0.48%
1,205,540
+365,972
+44% +$11.2M
WWD icon
71
Woodward
WWD
$22.1B
$34.9M 0.48%
513,913
+24,363
+5% +$1.69M
MNRO icon
72
Monro
MNRO
$399M
$34.5M 0.47%
662,280
+75,280
+13% +$4.27M
ABCO
73
DELISTED
Advisory Board Co
ABCO
$34.5M 0.47%
737,058
-288,921
-28% -$12.8M
CUDA
74
DELISTED
Barracuda Networks, Inc.
CUDA
$34.1M 0.47%
1,477,513
+151,848
+11% +$3.55M
QDEL icon
75
QuidelOrtho
QDEL
$1.17B
$34M 0.46%
1,503,151
+211,887
+16% +$4.38M

Similar funds

ArrowMark Colorado Holdings's Q1 2017 Portfolio in Review

As of Q1 2017, ArrowMark Colorado Holdings held 320 positions worth $7.33B, up 16% from $6.33B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

ArrowMark Colorado Holdings deployed $568M of net new capital in Q1 2017, opening 26 new positions and adding to 127 existing holdings. Its largest new stake was Casey's General Stores: 420,082 shares worth $47.2M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Hibbett, Inc. Common Stock, an estimated $34.8M trimmed.

  • ArrowMark Colorado Holdings's largest Q1 2017 buy was Casey's General Stores: 420,082 shares worth $47.2M.
  • ArrowMark Colorado Holdings added most to Callidus Software, Inc. in Q1 2017, an estimated $49.8M increase.
  • ArrowMark Colorado Holdings's biggest Q1 2017 reduction was Hibbett, Inc. Common Stock, cutting an estimated $34.8M.
  • ArrowMark Colorado Holdings fully exited Bats Global Markets, Inc. in Q1 2017, selling an estimated $69.4M.
  • ArrowMark Colorado Holdings's ten largest holdings make up 20% of its $7.33B portfolio in Q1 2017.
  • ArrowMark Colorado Holdings opened 26 new positions and closed 21 in Q1 2017.
  • ArrowMark Colorado Holdings's portfolio value rose 16% quarter-over-quarter to $7.33B.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2017, filed 15 May 2017.